News Release

Sulfur amino acid restriction enhances fat loss and metabolic health

Peer-Reviewed Publication

Higher Education Press

Figure 1

image: 

Schematic summary of the glucose and lipid metabolism in fasting and fed states.

view more 

Credit: Chenhao Xin, Mingcheng Cai, Qianxi Jia, Rong Huang, Rui Li, Junyao Wang, Zi Li, Qiang Zhao, Tianyi Liu, Weidong Zhuang, Jinyu Zhou, Shengxian Li, Yongzhen Tao, Lin Wang, Lifeng Yang

Obesity is a multifaceted chronic condition characterized by an excessive accumulation of fat, which significantly raises the risk of developing metabolic disorders like type 2 diabetes, fatty liver disease, and cardiovascular complications. While dietary strategies such as calorie restriction, time-restricted eating, and low-glycemic index diets offer promising means to manage obesity, they often struggle to achieve sustainable long-term results and may eventually result in weight regain.

 

Another attractive strategy is to regulate energy expenditure by adjusting specific nutrient intake. For example, a popular low-branched-chain amino acid (BCAA) diet has been shown to increase energy expenditure, improve glucose sensitivity, and reduce body weight, but its underlying mechanisms remain unclear. Research indicates that restricting dietary sulfur amino acids can enhance longevity and metabolic health, but its impact varies across study models, complicating dietary strategies for obesity management.

 

A recent study in Life Metabolism found that a sulfur amino acid restriction (SAAR) diet induces rapid fat loss and enhances glucose sensitivity in mice without impacting appetite or physical activity. Notably, its effects surpassed those of a BCAA-restricted diet. Metabolic analysis and in vivo isotope tracing revealed that SAAR-driven fat loss results from alterations in lipid synthesis, lipolysis, and fatty acid oxidation. Moreover, the study identified cystine, rather than methionine or its downstream metabolites, as a key regulator of fat metabolism with potential implications for weight management in diabetic patients. Furthermore, the researchers applied these findings to a disease model and evaluated their clinical relevance by measuring cystine levels in the plasma of diabetic patients. The study revealed a positive correlation between circulating cystine levels, body mass index (BMI), and total triglyceride levels, suggesting cystine as a potential regulator of obesity in diabetic individuals.

 

In summary, this study shows that the SAAR diet regulates glucose and lipid metabolism to support weight control without impacting appetite or physical activity (Figure 1), offering new insights into obesity management. The potential benefits and risks of a low-SAA diet in humans require further research to validate its molecular mechanisms and assess its clinical applications.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.